Clinical Trials Directory

Trials / Unknown

UnknownNCT04591522

Fecal Microbiota Transplantation in Cirrhosis

The Study of HIF-1α in Cirrhosis by Fecal Microbiota Transplantation

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
First Affiliated Hospital of Wenzhou Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Patients with cirrhosis were recruitted and divided into cintrol group and FMT group. Patients in FMT group were carried by fecal microbiota transplantation, and biochemical indexes, intestinal flora and intestinal HIF expression were observed before and after FMT respectively.

Conditions

Interventions

TypeNameDescription
OTHERHealthy fecal bacteria liquidFecal bacteria liquid were obtained from healthy people by a feces processor, and perfused into the patient's intestine.

Timeline

Start date
2020-10-15
Primary completion
2021-12-31
Completion
2022-06-30
First posted
2020-10-19
Last updated
2020-10-19

Source: ClinicalTrials.gov record NCT04591522. Inclusion in this directory is not an endorsement.